Apoptosis Antibodies
Apoptosis refers to the set of ordered biochemical and physical changes in a cell during a specific form of cell death. These changes begin with the rounding and shrinking of the affected cells causing them to lose contact with their neighbors. Later, their endoplasmic reticulum swells and the cisternae begin to form vesicles and vacuoles. In the nucleus, the chromatin condenses and is digested by endogenous nucleases. The nucleus ultimately disintegrates into fragments which are encapsulated into apoptotic bodies. By this point, the plasma membrane has become convoluted and begins blebbing off, forming the surface of the apoptotic bodies, which are then recognized and engulfed by phagocytic cells. In contrast, during necrosis the cell swells and disintegrates in a disordered manner, leading to the destruction of cellular organelles and the rupture of the plasma membrane.
ProSci has a wide variety of apoptosis antibodies. These include antibodies against p53 upregulated modulator of apoptosis (PUMA), Bim, members of the caspase family, death receptors, p53 and many other apoptosis proteins. Additionally, ProSci offers a BAFF and Receptor Detection Set and a TRAIL and Receptor Detection set. ProSci antibodies are appropriate for ELISA, western blot, and immunohistochemistry (IHC) applications as noted for each apoptosis antibody.
Also, we have a TRAIL and TRAIL receptor flyer in the posters section of our resources area of the ProSci website and our TRAIL and TRAIL receptor products were featured in our May 2006 newsletter which is also in the posters section of our resources area.
Apoptosis Antibodies from ProSci:
| Product Name | Catalog # | App. | Reactivity | Description |
|---|---|---|---|---|
| AATF Antibody | 28-980 | E, WB | H, M, R, D | AATF (apoptosis antagonizing transcription factor) |
| AATF Antibody | 3039 | E, WB, IHC, IF | H, M | (CT) An anti-apoptotic transcription factor |
| AATF Antibody | 28-979 | E, WB | H | AATF (apoptosis antagonizing transcription factor) |
| AATF Antibody | 27-426 | E, WB, IHC | H | AATF (apoptosis antagonizing transcription factor) |
| ACADM Antibody | 25-092 | E, WB | H | ACADM (acyl-Coenzyme A dehydrogenase, C-4 to C-12 |
| ACADM Antibody | 27-708 | E, WB | H, D | ACADM (acyl-Coenzyme A dehydrogenase, C-4 to C-12 |
| ACAT2 Antibody | 27-710 | E, WB, IHC | H | ACAT2 (acetyl-Coenzyme A acetyltransferase 2 (acet |
| ACAT2 Antibody | 27-709 | E, WB, IHC | H | ACAT2 (acetyl-Coenzyme A acetyltransferase 2 (acet |
| Acinus Antibody | 2217 | E, WB, ICC, IF | H | (CT) Inducer of chromatin condensation |
| Acinus Antibody | 2215 | E, WB, ICC, IF | H | (CT) Inducer of chromatin condensation |
| Acinus Antibody | 2219 | E, WB, ICC, IF | H | (IN) Inducer of chromatin condensation |
| Acinus Antibody | 2241 | E, WB | H | (NT) Inducer of chromatin condensation |
| ADAM10 Antibody | 49-378 | E, WB, IHC | M, R, C | A Disintegrin And Metalloproteinase Domain 10 |
| ADAM10 Antibody | 2051 | E, WB, ICC, IF | H | (CT) TNFalpha converting enzyme |
| AES Antibody | 3609 | E, WB, ICC, IF | H, M | (NT) Amino-terminal enhancer of split |
| AES Antibody | 3607 | E, WB, ICC, IF | H, M, R | (CT) Amino-terminal enhancer of split |
| AFX Antibody | 79-168 | WB, IHC, IF | H, M, R | AFX (Phospho-Ser197) |
| AFX Antibody | 79-343 | WB, IHC | H, M, R | AFX (Ab-197) |
| AHR Antibody | 27-379 | E, WB | H, M, D | AHR (aryl hydrocarbon receptor) |
| AHR Antibody | 27-527 | E, WB, IHC | H | AHR (aryl hydrocarbon receptor) |
| AIF Antibody | 2239 | E, WB, ICC, IF | H | (NT) Apoptosis Inducing Factor |
| AIF Antibody | 2267 | E, WB, IHC | H, M, R | (IN) Apoptosis Inducing Factor |
| AIF Antibody | 2301 | E, WB, ICC | H, M, R | (CT) Apoptosis Inducing Factor |
| AIFM1 Antibody | 49-571 | WB, IHC | H, M, R | Apoptosis-inducing Factor |
| AIFM1 Antibody | 49-526 | WB, IHC | H | Apoptosis-inducing Factor |
| AIFM3 Antibody | 42-278 | E | See Data | (IN) AIFM3 |
| AIFM3 Antibody | 4539 | E, WB, IHC, IF | H, M, R | (NT) Apoptosis-inducing factor mitochondrion-assoc |
| AIFM3 Antibody | 4541 | E, WB | H, M, R | (IN) Apoptosis-inducing factor mitochondrion-assoc |
| AIM Antibody | 3807 | E, WB, IHC, IF | H, M | (NT) apoptosis inhibitor of macrophages |
| AIM Antibody | 3805 | E, WB, IHC | H, M | (CT) apoptosis inhibitor of macrophages |
| Akt pan Antibody | XBP-4033 | WB | H, M | Akt pan |
| AKT Substrate Antibody | 39-852 | E, WB, IHC | H, M, R | Akt substrate 160 pT649 |
| Akt/PKB [pT308] Antibody | XBP-4034 | WB | H, M | Akt/PKB [pT308] |
| AKT1 Antibody | 31-053 | E, WB | H, M, D | AKT1 (v-akt murine thymoma viral oncogene homolog |
| Akt1 Antibody | 3519 | E, WB, IHC, IF | H, M, R | (NT) a serine/threonine kinase |
| AKT1 Antibody | XW-7020 | E | H | V-akt murine thymoma viral oncogene homolog 1 |
| AKT1 Antibody | 31-052 | E, WB | H, M, D | AKT1 (v-akt murine thymoma viral oncogene homolog |
| AKT1 Antibody | XW-7019 | WB | H, M, R, B, X | Serine/threonine protein kinase |
| AKT2 Antibody | XW-7021 | E | H | V-akt murine thymoma viral oncogene homolog 2 |
| AKT3 Antibody | XW-7022 | E | H | V-akt murine thymoma viral oncogene homolog 3 |
| AMFR Antibody | 29-818 | E, WB | H, M, R, D | AMFR (autocrine motility factor receptor) |
| Aminoadipate aminotransferase Antibody | 39-868 | E, WB, IHC | M | (NT) Kynurenine aminotransferase II |
| Apaf-1 Monoclonal Antibody | PM-2015 | E, WB, IHC | H, M, R | Apoptosis protease activator |
| Apaf-1 Monoclonal Antibody | PM-2016 | E, IHC | H, M, R | Apoptosis protease activator |
| APAF1 Antibody | XW-7034 | WB | H, M | Apoptotic protease activating factor 1 |
| Apaf1 Antibody | 2015 | E, WB, IHC | H, M, R | (CT) Apoptosis protease activating factor |
| APAF1 Antibody | 49-610 | WB, IHC | H, M, R | Apoptotic Protease Activating Factor 1 |
| Apaf1 Antibody | 2013 | E, WB, IHC, IF | H, M, R | (NT) Apoptotic protease activating factor 1 |
| APBB2 Antibody | 27-061 | E, WB | H, M, R | APBB2 (amyloid beta (A4) precursor protein-binding |
| APC2 Antibody | 30-627 | E, WB | H, M, R | APC2 (adenomatosis polyposis coli 2) |

